“…CVD can kill patients with CKD more often and more prematurely. The CVD spectrum in CKD and ESRD includes ischemic attributed to displaced transition of QRS complex, 3) Absent Q waves in leads I, V5 and V6 or a narrow Q wave in the absence of myocardial pathology in the lead aVL, 4) R peak time greater than 60 ms in leads V5and V6 but normal in leads V1, V2 and V3, when small initial R waves can be discerned in the above leads, 5) ST and T waves opposite in direction to QRS, 6) Positive T wave in leads with upright QRS, 7) Depressed ST segment and/or negative T wave in leads with negative QRS [ Inverted T wave deeper than mm [] Non-specific ST-T changes 1) No ST-T depression ≥ 0.5 mm but ST-segment down-sloping and ST-segment or T-wave nadir at least 0.5 mm below the P-R baseline in any of leads I, II, aVL, or V2 to V6 2) ST-J depression ≥1.0 mm and ST-segment up-sloping or U-shaped in any of leads I, II, aVL, or V1 to V6 3) T-wave amplitude zero (flat), negative, or diphasic (negative-positive type only) with <1.0 mm negative phase in leads I, II, aVL, or V3 to V6 when R-wave amplitude is ≥ 5.0 mm, 4) T-wave amplitude positive and T-to R-wave amplitude ratio of <1:20 in any of leads I, II, aVL, or V3 to V6 when R wave amplitude in the corresponding leads was ≥10.0 mm [46] Pathologic Q wave Any Q wave with more than ms width or a depth more than one-third of the adjacent R wave in more than two adjacent leads [ heart disease, congestive heart failure, arrhythmias and peripheral vascular disease. Initially, it was estimated that this only occurred in the ESRD population which was 20-30 times more likely to die from CVD compared to the general population.…”